Autism Spectrum Disorder

Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders

Autism spectrum disorders (ASDs), which include childhood autism, autistic disorder, Asperger syndrome, atypical autism, and other pervasive developmental disorders, are characterized by social and communication difficulties and by stereotyped or repetitive behaviors and interests. It [...]

By |2025-06-26T09:08:09-04:00October 15th, 2014|Anti-Epileptic Drugs, Autism Spectrum Disorder, Outcomes, Pregnancy & Medications|Comments Off on Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders

Prenatal Exposure to Antidepressants and Risk of Autism

It is estimated that autism spectrum disorders (ASD) affect about 1% to 2% of children.  Research carried out in twins and families indicate that ASD is highly heritable; however, it is generally believed that while  genetic factors play an important role, there is an interplay between genetic and environmental factors in the etiology of this disorder.  Various environmental exposures have been implicated, including vaccinations, mercury, air pollution, insecticides, and infection.

By |2015-08-06T09:41:13-04:00May 29th, 2013|Antidepressants, Autism Spectrum Disorder, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Prenatal Exposure to Antidepressants and Risk of Autism

Exposure to Valproic Acid and Increased Risk of Autism Spectrum Disorders

There have long been concerns regarding the use of the anticonvulsant valproate (Depakote, VPA) during pregnancy. First trimester use of valproate has been associated with a 3-5% risk of neural tube defects, as well as an increased risk of other malformations affecting the heart and other organ systems.  Multiple reports have also indicated that in utero exposure to valproate may also negatively affect cognitive development.

By |2025-06-26T09:08:14-04:00March 4th, 2013|Anti-Epileptic Drugs, Autism Spectrum Disorder, Mood Stabilizers, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Exposure to Valproic Acid and Increased Risk of Autism Spectrum Disorders

Autism Spectrum Disorders and SSRIs

It is now estimated that autism spectrum disorders (ASD) affect about 1% to 2% of the population.  Data derived from twin and sibling studies indicate that ASD is highly heritable.  While genetic factors clearly play an important role, other studies point to an interplay between environmental and genetic factors in the etiology of this disorder.  Over the years, various environmental exposures have been implicated, including vaccinations, mercury, and insecticides; however, it has been difficult to generate solid evidence linking specific environmental factors with increased risk for autism.

By |2024-07-24T11:49:06-04:00July 18th, 2011|Autism Spectrum Disorder, Child Outcomes, Pregnancy & Medications|Comments Off on Autism Spectrum Disorders and SSRIs
Go to Top